MedPath

PERICOLACE CAP

PERICOLACE CAP

Discontinued
DIN Number

00464872

Drug Class

Human

Market Date

Dec 31, 1957

Company
HC

bristol labs division of bristol-myers squibb

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00464872
AIG Number0204359001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB57 CASCARA, COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CASANTHRANOLActive
Strength: 30 MG / CAP
Monograph: CASANTHRANOL
DOCUSATE SODIUMActive
Strength: 100 MG / CAP
Monograph: DOCUSATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.